Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,397 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Levels of 4EBP1/eIF4E Activation in Renal Cell Carcinoma Could Differentially Predict Its Early and Late Recurrence.
Ichiyanagi O, Naito S, Ito H, Kabasawa T, Narisawa T, Kanno H, Kurota Y, Kurokawa M, Fukuhara H, Sakurai T, Nishida H, Kato T, Yamakawa M, Tsuchiya N. Ichiyanagi O, et al. Among authors: kato t. Clin Genitourin Cancer. 2018 Oct;16(5):e1029-e1058. doi: 10.1016/j.clgc.2018.06.002. Epub 2018 Jun 8. Clin Genitourin Cancer. 2018. PMID: 30297141 Free article.
Expression of total and phospho 4EBP1 in metastatic and non-metastatic renal cell carcinoma.
Naito S, Ichiyanagi O, Ito H, Kabasawa T, Kanno H, Narisawa T, Fukuhara H, Yagi M, Kurota Y, Yamagishi A, Sakurai T, Nishida H, Kawazoe H, Yamanobe T, Kato T, Makhov P, Kolenko VM, Yamakawa M, Tsuchiya N. Naito S, et al. Among authors: kato t. Oncol Lett. 2019 Apr;17(4):3910-3918. doi: 10.3892/ol.2019.10033. Epub 2019 Feb 12. Oncol Lett. 2019. PMID: 30881508 Free PMC article.
Impact of eIF4E phosphorylation at Ser209 via MNK2a on tumour recurrence after curative surgery in localized clear cell renal cell carcinoma.
Ichiyanagi O, Ito H, Naito S, Kabasawa T, Kanno H, Narisawa T, Ushijima M, Kurota Y, Ozawa M, Sakurai T, Nishida H, Kato T, Yamakawa M, Tsuchiya N. Ichiyanagi O, et al. Among authors: kato t. Oncotarget. 2019 Jun 18;10(40):4053-4068. doi: 10.18632/oncotarget.27017. eCollection 2019 Jun 18. Oncotarget. 2019. PMID: 31258849 Free PMC article.
Effect of third- and fourth-line systemic therapies for metastatic renal cell carcinoma.
Naito S, Ichiyanagi O, Kato T, Kanno H, Narisawa T, Kurokawa M, Ushijima M, Ozawa M, Yagi M, Kurota Y, Fukuhara H, Yamagishi A, Sakurai T, Nishida H, Kawazoe H, Yamanobe T, Tsuchiya N. Naito S, et al. Among authors: kato t. Sci Rep. 2019 Oct 29;9(1):15451. doi: 10.1038/s41598-019-51305-7. Sci Rep. 2019. PMID: 31664053 Free PMC article.
New prognostic model for synchronous metastatic renal cell carcinoma.
Naito S, Kato T, Ichiyanagi O, Narisawa T, Kurokawa M, Yagi M, Ushijima M, Ozawa M, Kanno H, Kurota Y, Fukuhara H, Kuboki Y, Yamagishi A, Sakurai T, Nishida H, Yamanobe T, Tsuchiya N. Naito S, et al. Among authors: kato t. Int J Urol. 2020 May;27(5):448-456. doi: 10.1111/iju.14215. Epub 2020 Mar 23. Int J Urol. 2020. PMID: 32207204
GPI-80 Augments NF-κB Activation in Tumor Cells.
Takeda Y, Kurota Y, Kato T, Ito H, Araki A, Nara H, Saitoh S, Tanaka N, Tsuchiya N, Asao H. Takeda Y, et al. Among authors: kato t. Int J Mol Sci. 2021 Nov 6;22(21):12027. doi: 10.3390/ijms222112027. Int J Mol Sci. 2021. PMID: 34769456 Free PMC article.
12,397 results
You have reached the last available page of results. Please see the User Guide for more information.